Addition of H19 ‘Loss of Methylation Testing’ for Beckwith-Wiedemann Syndrome (BWS) Increases the Diagnostic Yield  Jochen K. Lennerz, Robert J. Timmerman,

Slides:



Advertisements
Similar presentations
Chris Campbell West Midlands Regional Genetics laboratory
Advertisements

Margaret L. Gulley, Thomas C. Shea, Yuri Fedoriw 
Clinical Laboratory Analysis of Immunoglobulin Heavy Chain Variable Region Genes for Chronic Lymphocytic Leukemia Prognosis  Philippe Szankasi, David.
Distribution of CpG dinucleotide in the human genome and differences in methylation patterns between normal and tumor cells. In the majority of the mammalian.
Deletions of the INK4A Gene Occur in Malignant Peripheral Nerve Sheath Tumors but not in Neurofibromas  Helen P. Kourea, Irene Orlow, Bernd W. Scheithauer,
Imprinting-Mutation Mechanisms in Prader-Willi Syndrome
Sensitivity Analysis of the MGMT-STP27 Model and Impact of Genetic and Epigenetic Context to Predict the MGMT Methylation Status in Gliomas and Other.
Sensitivity Analysis of the MGMT-STP27 Model and Impact of Genetic and Epigenetic Context to Predict the MGMT Methylation Status in Gliomas and Other.
Tracy I. George, Joanna E. Wrede, Charles D. Bangs, Athena M
Nat. Rev. Endocrinol. doi: /nrendo
Laila C. Schenkel, Charles Schwartz, Cindy Skinner, David I
Margaret L. Gulley, Thomas C. Shea, Yuri Fedoriw 
Genome-Wide Identification and Validation of a Novel Methylation Biomarker, SDC2, for Blood-Based Detection of Colorectal Cancer  TaeJeong Oh, Nayoung.
A Pseudo-Full Mutation Identified in Fragile X Assay Reveals a Novel Base Change Abolishing an EcoRI Restriction Site  Shujian Liang, Harold N. Bass,
Molecular Genetics of Pediatric Soft Tissue Tumors
Embryonic imprinting perturbations do not originate from superovulation-induced defects in DNA methylation acquisition  Michelle M. Denomme, B.Sc., Liyue.
In Vitro Fertilization May Increase the Risk of Beckwith-Wiedemann Syndrome Related to the Abnormal Imprinting of the KCNQ1OT Gene  Christine Gicquel,
Methylation-Specific Multiplex Ligation-Dependent Probe Amplification Enables a Rapid and Reliable Distinction between Male FMR1 Premutation and Full-Mutation.
Gene Dysregulations Driven by Somatic Copy Number Aberrations-Biological and Clinical Implications in Colon Tumors  Manny D. Bacolod, Francis Barany 
Detection of Aberrant TERT Promoter Methylation by Combined Bisulfite Restriction Enzyme Analysis for Cancer Diagnosis  Seungjae Lee, Sumit Borah, Armita.
Discordance between Genetic and Epigenetic Defects in Pseudohypoparathyroidism Type 1b Revealed by Inconsistent Loss of Maternal Imprinting at GNAS1 
Philippe Szankasi, Mohamed Jama, David W. Bahler 
Volume 126, Issue 4, Pages (April 2004)
Figure 3 The Beckwith–Wiedemann syndrome locus at chromosome 11p15.5
Multiplex Ligation-Dependent Probe Amplification
Down Syndrome and Malignancies: A Unique Clinical Relationship
Clinical Validation of a Genome-Wide DNA Methylation Assay for Molecular Diagnosis of Imprinting Disorders  Erfan Aref-Eshghi, Laila C. Schenkel, Hanxin.
Undifferentiated Small Round Cell Sarcomas with Rare EWS Gene Fusions
Customized Oligonucleotide Array-Based Comparative Genomic Hybridization as a Clinical Assay for Genomic Profiling of Chronic Lymphocytic Leukemia  Rachel.
Sequencing of t(2;7) Translocations Reveals a Consistent Breakpoint Linking CDK6 to the IGK Locus in Indolent B-Cell Neoplasia  Edward P.K. Parker, Reiner.
Qing Cheng, Cheng Cheng, Kristine R. Crews, Raul C
Detection of an Apparent Homozygous 3120G>A Cystic Fibrosis Mutation on a Routine Carrier Screen  Denise LaMarche Heaney, Patrick Flume, Lauren Hamilton,
Shaoyu Zhou, Keyaunoosh Kassauei, David J. Cutler, Giulia C
Identification of Recombinant Alleles Using Quantitative Real-Time PCR
T. Ohta, K. Buiting, H. Kokkonen, S. McCandless, S. Heeger, H
Differential DNA Methylation as a Tool for Noninvasive Prenatal Diagnosis (NIPD) of X Chromosome Aneuploidies  Floriana Della Ragione, Paola Mastrovito,
Surpassing Specificity Limits of Nucleic Acid Probes via Cooperativity
Clinical Laboratory Analysis of Immunoglobulin Heavy Chain Variable Region Genes for Chronic Lymphocytic Leukemia Prognosis  Philippe Szankasi, David.
Assessing loss of imprint methylation in sperm from subfertile men using novel methylation polymerase chain reaction Luminex analysis  Akiko Sato, M.E.,
Catherine E. Keegan, Anthony A. Killeen 
Janice M. Spence, Paul G. Rothberg, Nancy Wang, W. Richard Burack 
Human Epidermal Differentiation Complex in a Single 2
Clinical Categories of Neuroblastoma Are Associated with Different Patterns of Loss of Heterozygosity on Chromosome Arm 1p  Jaume Mora, Nai-Kong V. Cheung,
Benjamin P. Song, Surbhi Jain, Selena Y. Lin, Quan Chen, Timothy M
S. Hussain Askree, Shika Dharamrup, Lawrence N. Hjelm, Bradford Coffee 
Figure 2 Flowchart for investigation and diagnosis of Beckwith– Wiedemann syndrome Figure 2 | Flowchart for investigation and diagnosis of Beckwith– Wiedemann.
Comprehensive Mutation Analysis of the CYP21A2 Gene
Syed Hussain Askree, Lawrence N
Global Patterns of Methylation in Sézary Syndrome Provide Insight into the Role of Epigenetics in Cutaneous T-Cell Lymphoma  Sean Whittaker  Journal of.
Detection and Discrimination between Deletional and Non-Deletional Prader-Willi and Angelman Syndromes by Methylation-Specific PCR and Quantitative Melting.
Volume 23, Issue 1, Pages 9-22 (January 2013)
Imprinting at the SMPD1 Locus: Implications for Acid Sphingomyelinase–Deficient Niemann-Pick Disease  Calogera M. Simonaro, Jae-Ho Park, Efrat Eliyahu,
Array Comparative Genomic Hybridization Detects Chromosomal Abnormalities in Hematological Cancers That Are Not Detected by Conventional Cytogenetics 
Genomic Technologies and the New Era of Genomic Medicine
DNA and RNA References for qRT-PCR Assays in Exfoliated Cervical Cells
A Physical Map, Including a BAC/PAC Clone Contig, of the Williams-Beuren Syndrome– Deletion Region at 7q11.23  Risa Peoples, Yvonne Franke, Yu-Ker Wang,
Imprinted Chromatin around DIRAS3 Regulates Alternative Splicing of GNG12-AS1, a Long Noncoding RNA  Malwina Niemczyk, Yoko Ito, Joanna Huddleston, Anna.
Novel Polymorphism in the FMR1 Gene Resulting in a “Pseudodeletion” of FMR1 in a Commonly Used Fragile X Assay  Thomas M. Daly, Arash Rafii, Rick A. Martin,
Katy Hanlon, Lorna W. Harries, Sian Ellard, Claudius E. Rudin 
Gene Dysregulations Driven by Somatic Copy Number Aberrations-Biological and Clinical Implications in Colon Tumors  Manny D. Bacolod, Francis Barany 
Epigenetic Control of the S100A6 (Calcyclin) Gene Expression
Association of In Vitro Fertilization with Beckwith-Wiedemann Syndrome and Epigenetic Alterations of LIT1 and H19  Michael R. DeBaun, Emily L. Niemitz,
Genomic imprinting Current Biology
Identification of TSIX, Encoding an RNA Antisense to Human XIST, Reveals Differences from its Murine Counterpart: Implications for X Inactivation  Barbara.
A Complex Rearrangement in the APC Gene Uncovered by Multiplex Ligation- Dependent Probe Amplification  Constanze Pagenstecher, Dorothea Gadzicki, Dietlinde.
Addition of H19 ‘Loss of Methylation Testing’ for Beckwith-Wiedemann Syndrome (BWS) Increases the Diagnostic Yield  Jochen K. Lennerz, Robert J. Timmerman,
Addition of H19 ‘Loss of Methylation Testing’ for Beckwith-Wiedemann Syndrome (BWS) Increases the Diagnostic Yield  Jochen K. Lennerz, Robert J. Timmerman,
Transcriptional control: Imprinting insulation
Qing Cheng, Cheng Cheng, Kristine R. Crews, Raul C
K. Miura, M. Obama, K. Yun, H. Masuzaki, Y. Ikeda, S. Yoshimura, T
Presentation transcript:

Addition of H19 ‘Loss of Methylation Testing’ for Beckwith-Wiedemann Syndrome (BWS) Increases the Diagnostic Yield  Jochen K. Lennerz, Robert J. Timmerman, Dorothy K. Grange, Michael R. DeBaun, Andrew P. Feinberg, Barbara A. Zehnbauer  The Journal of Molecular Diagnostics  Volume 12, Issue 5, Pages 576-588 (September 2010) DOI: 10.2353/jmoldx.2010.100005 Copyright © 2010 American Society for Investigative Pathology and Association for Molecular Pathology Terms and Conditions

Figure 1 Normal and abnormal methylation in Beckwith-Wiedemann syndrome. A: Location of markers used for UPD-analysis (filled circles, practice group; open circles, validation group). B: Chromosomal region 11p15.5 involved in BWS-associated genomic imprinting defects. With the exception of IGF2 and LIT1, all imprinted genes are expressed (open boxes) from the maternal allele (arrows in transcription direction); silenced genes, black boxes. C: The region can be divided into a centromeric and telomeric domain. Mitsuya et al16 described the existence of a long QT intronic transcript (LIT1) within KCNQ1OT1 that was transcribed in antisense orientation and is referred to as KCNQ1 overlapping transcript 1 (KCNQ1OT1). The assay targets a NotI site in the CpG island within intron 10 of the KCNQ1 gene and at the 5′ end of KCNQ1OT1 known as DMR21718 (synonyms are IC2, ICR2, BWSIC2 and KvDMR1). H19 is also known as BWS, and the assay targets a SmaI site 5 kb upstream of the H19 promoter between exon 3 and 4 of IGF2 known as DMR119 (synonyms are: IC1, ICR1, BWSIC1, H19DMR, and CTCF binding region). Because DMR2 can refer to a centromeric1720 or telomeric19 methylation center, in the diagnostic setting LIT1/H19 are the preferred terms. Other differentially methylated regions (DMR) upstream of H19, not assayed here, are depicted (DMR0 located 5′ of the main IGF2 promoter,20 and DMR2 located between intron 7 and 9 of IGF219); composed after previous studies.7132223242526272829303132333435363738 D: Validation of cloned probe DNA fragments in a known BWS-UPD case. There are no methylated LIT1 and no unmethylated H19 bands; methylation index (MI) = top band/sum approximates 0 and 1, respectively. NL, nonaffected individual; BWS, clinical diagnosis of BWS. The Journal of Molecular Diagnostics 2010 12, 576-588DOI: (10.2353/jmoldx.2010.100005) Copyright © 2010 American Society for Investigative Pathology and Association for Molecular Pathology Terms and Conditions

Figure 2 Threshold determination in BWS via methylation hybridization. A: Examples of autoradiographs from the validation group for the two loci. Absence of maternal methylation pattern is more obvious and complete in LIT1 when compared with the mostly incomplete hypermethylation of H19. Methylation index (MI) = top band/sum (see Materials and Methods) provided below. B: Based on the methylation indices for the validation group, diagnostic thresholds for the diagnosis of BWS were determined as <0.38 (LIT1) and >0.65 (H19), corresponding to mean control ± 2 σ (details see methods; P values provided in Table 3). NL, nonaffected individual; BWS, clinical diagnosis of BWS. The Journal of Molecular Diagnostics 2010 12, 576-588DOI: (10.2353/jmoldx.2010.100005) Copyright © 2010 American Society for Investigative Pathology and Association for Molecular Pathology Terms and Conditions

Figure 3 Addition of H19 increases diagnostic yield. A: In the validation group, the addition of H19-testing allows detection of four additional patients in the LIT1-normal group, which corresponds to ∼8% increased detection. B: In the practice group, the addition of H19 allows identification of 62 additional patients, missed by LIT1 testing alone. This corresponds to an overall ∼5% increased detection rate. C: Southern blot examples from the practice group illustrate the four possible band combinations and are shown as LIT1 and H19 combinations (although run as separate tests). The diagnostic interpretation (Interpr.) is provided under the methylation index (MI) = top band/sum (see Materials and Methods). +, abnormal; −, normal methylation. The Journal of Molecular Diagnostics 2010 12, 576-588DOI: (10.2353/jmoldx.2010.100005) Copyright © 2010 American Society for Investigative Pathology and Association for Molecular Pathology Terms and Conditions

Figure 4 Diagnostic algorithm and molecular diagnostic approach in BWS. A: The diagnostic algorithm follows clinical (phenotypic) features and key examples are provided to illustrate the following interrelation: with decreasing clinical suspicion of BWS, the rate of molecular detection decreases; however, clinical variability or specific settings may trigger testing and confirm abnormal methylation in ‘mild phenotypes’ or hemihyperplasia64142434445 (for comprehensive coverage of clinical features see Refs.78910597172737475). As a visual estimate, the detection rates in the validation and practice group are provided (gray background). B: Epigenetic testing and assessment of uniparental disomy (UPD) should be combined, and the required samples are listed. Finally, the interpretation of the test result and institution of tumor surveillance procedures requires clinical correlation and additional diagnostic testing (eg, cytogenetics or CDKN1C sequencing). The Journal of Molecular Diagnostics 2010 12, 576-588DOI: (10.2353/jmoldx.2010.100005) Copyright © 2010 American Society for Investigative Pathology and Association for Molecular Pathology Terms and Conditions